EU Awards $5.3M to Consortium Developing RNAi Screening Methods | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cytoo will coordinate a project announced on Monday that aims to combine high-throughput applications of RNAi with Cytoo's new cell normalization technology.

As part of the project, being funded with €4 million ($5.3 million) over three years under the European Commission's Seventh Framework Programme, Cytoo will partner with Cenix BioScience, Bioquant/Heidelberg University, École Polytechnique Fédérale de Lausanne, and Institute FTMC.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: researchers identify the characteristic genomic features of clear cell renal cell carcinoma, and more.

A technology that has the potential to make species go extinct could be used against the Zika virus. 

University of the Republic postdoc Victor Morais says researchers should be careful of the open access journals they choose to publish in.

If science funding agencies can talk tough about sexual harassers, shouldn't they also put their talk into action?